登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式(希尔记法):
C23H30ClN3O · 2HCl
化学文摘社编号:
分子量:
472.88
NACRES:
NA.77
UNSPSC Code:
12352101
Beilstein/REAXYS Number:
4834013
MDL number:
Assay:
≥98% (HPLC)
Form:
solid
Quality level:
Storage condition:
OK to freeze, desiccated (hygroscopic), protect from light
Quality Level
description
Merck USA index - 14, 8044
assay
≥98% (HPLC)
form
solid
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze, desiccated (hygroscopic), protect from light
color
yellow
solubility
water: soluble
shipped in
ambient
storage temp.
10-30°C
SMILES string
Cl[H].Cl[H].CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc3ccc(OC)cc13
InChI
1S/C23H30ClN3O.2ClH/c1-5-27(6-2)13-7-8-16(3)25-23-19-11-9-17(24)14-22(19)26-21-12-10-18(28-4)15-20(21)23;;/h9-12,14-16H,5-8,13H2,1-4H3,(H,25,26);2*1H
InChI key
UDKVBVICMUEIKS-UHFFFAOYSA-N
General description
一种非特异性磷脂酶A2 (PLA2)抑制剂。作为乙酰胆碱受体拮抗剂。抑制格列本脲敏感的K+-电流 (IC50 = 4.4 µM)。还抑制单胺氧化酶(MAO)。
Biochem/physiol Actions
产物不与ATP竞争。
可逆:否
细胞可渗透性:否
非选择性 MAO-A/B 抑制剂。
靶标IC50:4.4 µM,抑制格列本脲敏感的K+-电流
Preparation Note
贮备溶液在20°C下可稳定保存至多60个月。
Other Notes
Holscher, C. 1995.Neurobiol.Learn.Mem.63, 206.
Sakuta, H. and Yoneda, I. 1994.Eur. J. Pharmacol.252, 117.
Sargent, C.A., et al 1992.J. Pharmacol.Exp.Ther.262, 1161.
Voorhis, B.J., et al. 1992.Invertebr.Reprod.Dev.21, 33.
Murakami, M., et al. 1991.Biochem.Biophys.Res. Commun.181, 714.
Sakuta, H. and Yoneda, I. 1994.Eur. J. Pharmacol.252, 117.
Sargent, C.A., et al 1992.J. Pharmacol.Exp.Ther.262, 1161.
Voorhis, B.J., et al. 1992.Invertebr.Reprod.Dev.21, 33.
Murakami, M., et al. 1991.Biochem.Biophys.Res. Commun.181, 714.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
毒性:有害(C)
Still not finding the right product?
Explore all of our products under 喹吖因 二盐酸盐
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral
存储类别
11 - Combustible Solids
wgk
WGK 3
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 551850-100MG | 04055977268287 |
